These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 28264468)

  • 1. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
    Torre BG; Albericio F
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    G de la Torre B; Albericio F
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30813407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32050446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    Torre BG; Albericio F
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33504104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the physicochemical properties of marketed drugs: can history foretell the future?
    Faller B; Ottaviani G; Ertl P; Berellini G; Collis A
    Drug Discov Today; 2011 Nov; 16(21-22):976-84. PubMed ID: 21782967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug approvals for 2021: Synthesis and clinical applications.
    Yuan S; Wang DS; Liu H; Zhang SN; Yang WG; Lv M; Zhou YX; Zhang SY; Song J; Liu HM
    Eur J Med Chem; 2023 Jan; 245(Pt 1):114898. PubMed ID: 36370552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent drug approvals from the US FDA and EMEA: what the future holds.
    Pevarello P
    Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019.
    Bharate SS
    Drug Discov Today; 2021 Feb; 26(2):384-398. PubMed ID: 33221522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drug and biological product approvals, 2011.
    Traynor K
    Am J Health Syst Pharm; 2012 Feb; 69(3):180-2. PubMed ID: 22261935
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and regulatory features of drugs not initially approved by the FDA.
    Wang B; Avorn J; Kesselheim AS
    Clin Pharmacol Ther; 2013 Dec; 94(6):670-7. PubMed ID: 23963252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmaceuticals approved by FDA in 2020: Small-molecule drugs derived from amino acids and related compounds.
    Liu A; Han J; Nakano A; Konno H; Moriwaki H; Abe H; Izawa K; Soloshonok VA
    Chirality; 2022 Jan; 34(1):86-103. PubMed ID: 34713503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug and biological product approvals, 2004.
    Traynor K
    Am J Health Syst Pharm; 2005 Feb; 62(4):348, 350. PubMed ID: 15745882
    [No Abstract]   [Full Text] [Related]  

  • 18. New FDA oncology small molecule drugs approvals in 2020: Mechanism of action and clinical applications.
    Cristina Mendonça Nogueira T; Vinicius Nora de Souza M
    Bioorg Med Chem; 2021 Sep; 46():116340. PubMed ID: 34416511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Chemical Space of Known and Readily Obtainable Natural Products.
    Chen Y; Garcia de Lomana M; Friedrich NO; Kirchmair J
    J Chem Inf Model; 2018 Aug; 58(8):1518-1532. PubMed ID: 30010333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The year's new drugs & biologics, 2011.
    Graul AI; Cruces E; Dulsat C; Arias E; Stringer M
    Drugs Today (Barc); 2012 Jan; 48(1):33-77. PubMed ID: 22384459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.